Skip to main content
. 2023 Sep 30;20(19):6868. doi: 10.3390/ijerph20196868

Figure 1.

Figure 1

The effects of PFHxS on the viability of HCC and LSEC. Hep3B (A) and SK-Hep1 (B) cells were treated with the indicated concentrations of PFHxS for 24 and 48 h. Cell viability was measured using an MTT assay. Data represent the mean ± SEM (n = 3–4) (* p < 0.05, ** p < 0.01 and *** p < 0.001 vs. 24 h control; # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. 48 h control).